Latest Brain tumor Stories
Patients Too Sick for Enrollment in Phase III Trial for Newly Diagnosed GBM BETHESDA, Md., March 27, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc.
New technology for rapidly and precisely targeting tumors with image-guided radiosurgery is on display this week at the 27th International Medical Instruments & Equipment Exhibition BEIJING,
Researchers have developed an experimental drug to treat brain tumors by targeting the mitochondria. While it went well in mice, human trials are expected to happen very soon.
Multidisciplinary program provides neuroscience and radiation oncology expertise to patients CHARLESTON, S.C., March 25, 2015 /PRNewswire/ -- The Neurosciences Gamma Knife Center,
The co-chairs announce the Northwestern Brain Tumor Institute Minds Matter 2015 Fundraising Gala for May 1, 2015 CHICAGO, March 24, 2015 /PRNewswire-USNewswire/ -- One day in 2009,
BETHESDA, Md., March 24, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies
Researchers at NYU Langone Medical Center Project a National Influx of Patients Who Will Need Immediate Treatment NEW YORK, March 19, 2015 /PRNewswire-USNewswire/ -- By 2030, chronic
Oncology team hopeful their research will help address major challenges in treating high-grade gliomas, including glioblastoma HACKENSACK, N.J., March 18, 2015 /PRNewswire-USNewswire/
--Limited number of guaranteed entries available-- Chicago, Ill.
- Duke Cancer Institute researchers publish Phase 1/2 study results in Nature providing human proof-of-concept for new solid tumor target and "immune pre-conditioning" approach to cancer immunotherapy.
- The governor of a province or people.